Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Options Medical Weight Loss vs Steady State Health

Options Medical Weight Loss
Graded #218

Higher grade

vs+10.600000000000001
Steady State Health
Graded #451

Lower grade

The verdict

Options Medical Weight Loss takes it — 65.5/100 to 54.9/100.

Options Medical Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month, plus NAD+ injections at…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOptions Medical Weight Loss +9
54
45
Dose & formulationOptions Medical Weight Loss +37
77
40
Clinical oversightOptions Medical Weight Loss +3
81
78
Labs & monitoringOptions Medical Weight Loss +1
53
52
FulfillmentOptions Medical Weight Loss +2
67
65
Contract termsEven
55
55
Options Medical Weight Loss · left barSteady State Health · right bar

The numbers

MetricOptions Medical Weight LossSteady State Health
WeighScore65.5/10054.9/100
GradeCC
Scorecard rank#218#451
Semaglutide$199/mo (compounded)Not disclosed
Tirzepatide$399/mo (compounded)Not disclosed
CoverageCoverage not published2 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only

Strengths

  • LegitScript certified with clear, upfront program pricing
  • Compounded semaglutide (~$239) and tirzepatide (from $299), plus NAD+
  • Structured metabolic-health program with provider support and accountability
  • HSA/FSA eligible with flexible payment options

Where it loses points

  • Doesn't clearly publish which states its telehealth covers
  • Tirzepatide tiers climb to $339-$399/month
  • More program structure (and cost) than medication-only sellers
  • Compounded GLP-1 only online — no brand-name options noted
Steady State Health

Graded #451 · C

Strengths

  • Prescribes semaglutide or tirzepatide within a perimenopause and menopause hormone-and-metabolic care plan
  • Care delivered by a named women's-health nurse practitioner (Josie Cowburn, DNP, FNP-C)
  • Transparent flat program fee from $139/mo, with a $99/mo standalone GLP-1 support option

Where it loses points

  • Available only to Oregon and Washington residents
  • GLP-1 medication is billed separately by the pharmacy and not included in the program fee
  • Dispensing pharmacy is not publicly named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard